Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850654 · ClinicalTrials.gov registry record · NA
Ohio Colorectal Cancer Prevention Initiative
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 3,470
- Enrollment target
NCT01850654 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 3,470 participants.
The verdict
NCT01850654, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,470 participants
- Enrollment target
Study Summary
The purpose of the Ohio Colorectal Cancer Prevention Initiative (OCCPI) is to reduce morbidity and mortality due to colorectal cancer (CRC) in the state of Ohio. By identifying individuals at high-risk for CRC (genetically predisposed) and providing screening recommendations for cancer risk reduction, the OCCPI will understand how to increase length of life and quality of life for those diagnosed with CRC in Ohio, as well as to better prevent CRC in others in Ohio. Participants will have free tumor screening for Lynch syndrome, and may be eligible for free genetic testing and free genetic counseling as part of this study.
Interventions
- BEHAVIORAL Questionnaire
- GENETIC Genetic testing
- OTHER Biorepository
- BEHAVIORAL Genetic Counseling
- GENETIC LS tumor screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,470 participants |
| Start Date | 2012-12-26 |
| Est. Completion | 2018-01-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01850654
The ClinicalTrials.gov registry entry for NCT01850654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,470 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire is the first listed.
NCT01850654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01850654 about?
NCT01850654 is a clinical study titled "Ohio Colorectal Cancer Prevention Initiative". The purpose of the Ohio Colorectal Cancer Prevention Initiative (OCCPI) is to reduce morbidity and mortality due to colorectal cancer (CRC) in the state of Ohio. By identifying individuals at high-risk for CRC (genetically predisposed) and providing screening recommendations for cancer risk reductio...
What is the current status of trial NCT01850654?
This trial is currently completed. It is a NA study. The enrollment target is 3,470 participants. The study started on 2012-12-26. Estimated completion is 2018-01-02.
What interventions are being tested in trial NCT01850654?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Genetic testing (GENETIC), Biorepository (OTHER), Genetic Counseling (BEHAVIORAL), LS tumor screening (GENETIC).
Who is sponsoring clinical trial NCT01850654?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.